Proposed strategy for optimizing aldosterone blockade in heart failure

被引：3

作者：

Jolobe, Oscar M. P. ^{[1
]}

机构：

[1] John Ryland Univ Lib, Manchester Med Soc, Manchester M13 9PP, Lancs, England

来源：

AMERICAN HEART JOURNAL | 2012年 / 164卷 / 02期

关键词：

SPIRONOLACTONE; DIURETICS; THERAPY;

D O I：

10.1016/j.ahj.2012.06.004

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：131 / 131

页数：1

共 5 条

[1]

BAYLISS J, 1987, BRIT HEART J, V57, P17

[2]

COMBINED SPIRONOLACTONE AND CONVERTING-ENZYME-INHIBITOR THERAPY FOR REFRACTORY HEART-FAILURE [J].

IKRAM, H ;

WEBSTER, MWI ;

NICHOLLS, MG ;

LEWIS, GRJ ;

RICHARDS, AM ;

CROZIER, IG .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1986, 16 (01) :61-63

[3]

Effects of loor diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure [J].

López, B ;

Querejeta, R ;

González, A ;

Sánchez, E ;

Larman, M ;

Díez, J .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (11) :2028-2035

[4]

Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy [J].

Maeder, Micha T. ;

Rickli, Hans ;

Pfisterer, Matthias E. ;

Muzzarelli, Stefano ;

Ammann, Peter ;

Fehr, Thomas ;

Hack, Dietrich ;

Weilenmann, Daniel ;

Dieterle, Thomas ;

Kiencke, Stephanie ;

Estlinbaum, Werner ;

Brunner-La Rocca, Hans-Peter .

AMERICAN HEART JOURNAL, 2012, 163 (03) :407-U353

[5]

The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].

Pitt, B ;

Zannad, F ;

Remme, WJ ;

Cody, R ;

Castaigne, A ;

Perez, A ;

Palensky, J ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717

← 1 →